DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-08-01 22:45 |
Rapport Financier du Premier Semestre 2022
|
French | 4.8 MB | ||
| 2022-08-01 22:30 |
DBV Technologies Reports Second Quarter 2022 Financial Results
|
English | 421.4 KB | ||
| 2022-08-01 22:30 |
DBV Technologies publie ses résultats financiers du deuxième trimestre 2022
|
French | 364.7 KB | ||
| 2022-08-01 22:30 |
Rapport Financier du Premier Semestre 2022
|
French | 4.8 MB | ||
| 2022-07-27 22:30 |
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
|
English | 129.9 KB | ||
| 2022-07-27 22:30 |
Bilan semestriel du contrat de liquidité DBV Technologies avec ODDO BHF
|
French | 132.2 KB | ||
| 2022-07-20 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 128.7 KB | ||
| 2022-07-20 22:30 |
Monthly information regarding the total number of voting rights and total numb…
|
English | 87.0 KB | ||
| 2022-06-30 18:36 |
Franchissement de seuils et déclaration d'intention
|
French | 355.6 KB | ||
| 2022-06-29 00:15 |
DBV Technologies participera au prochain congrès EAACI 2022
|
French | 243.5 KB | ||
| 2022-06-29 00:15 |
DBV Technologies to Participate in Upcoming EAACI 2022 Congress
|
English | 240.3 KB | ||
| 2022-06-20 09:04 |
Franchissements de seuils
|
French | 277.4 KB | ||
| 2022-06-17 14:58 |
Franchissements de seuils et déclaration d'intention
|
French | 347.9 KB | ||
| 2022-06-16 07:30 |
DBV Technologies to Present at the JMP Securities Life Sciences Conference in N…
|
English | 134.9 KB | ||
| 2022-06-16 07:30 |
DBV Technologies invitée à présenter à la conférence JMP Securities Life Scienc…
|
French | 180.4 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
